Assignee
KUDOS PHARM LTD
GB·30 granted patents·12 pending applications·257 citations·filing 1998–2024
Top patents by PatentIndex Score
42 records- 0197US7449464B2Phthalazinone derivativesKUDOS PHARM LTD·Filed 2004·Granted Nov 11, 2008·69 cites·2 claims
- 0296US11633396B2Immediate release pharmaceutical formulation of 4-[3-(4- cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2H- phthalazin-1-oneKUDOS PHARM LTD·Filed 2022·Granted Apr 25, 2023·8 cites·30 claims
- 0395US7662818B2Phthalazinone derivativesKUDOS PHARM LTD·Filed 2005·Granted Feb 16, 2010·20 cites·7 claims
- 0491US7981889B2Phthalazinone derivativesKUDOS PHARM LTD·Filed 2008·Granted Jul 19, 2011·17 cites·9 claims
- 0591US7692006B2Phthalazinone derivativesKUDOS PHARM LTD·Filed 2007·Granted Apr 6, 2010·28 cites·7 claims
- 0691US7504397B2mTOR inhibitor compoundsKUDOS PHARM LTD·Filed 2006·Granted Mar 17, 2009·12 cites·14 claims
- 0790US12178816B2Immediate release pharmaceutical formulation of 4-[3-(4-cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2H-phthalazin-1-oneKUDOS PHARM LTD·Filed 2024·Granted Dec 31, 2024·0 cites·30 claims
- 0890US12144810B1Immediate release pharmaceutical formulation of 4-[3-(4-cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2H-phthalazin-1-oneKUDOS PHARM LTD·Filed 2024·Granted Nov 19, 2024·0 cites·30 claims
- 0990US9102670B2Pyrido-, pyrazo- and pyrimido-pyrimidine derivatives as mTOR inhibitorsKUDOS PHARM LTD·Filed 2013·Granted Aug 11, 2015·5 cites·6 claims
- 1090US7402607B2DNA-PK inhibitorsKUDOS PHARM LTD·Filed 2005·Granted Jul 22, 2008·16 cites·13 claims
- 1188US7750006B2Phthalazinone derivativesKUDOS PHARM LTD·Filed 2006·Granted Jul 6, 2010·7 cites·2 claims
- 1287US9566276B2Phthalazinone derivativesKUDOS PHARM LTD·Filed 2015·Granted Feb 14, 2017·4 cites·12 claims
- 1387US7470688B2Phthalazinone derivativesKUDOS PHARM LTD·Filed 2006·Granted Dec 30, 2008·10 cites·14 claims
- 1486US12048695B2Immediate release pharmaceutical formulation of 4-[3-(4-cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2H-phthalazin-1-oneKUDOS PHARM LTD·Filed 2023·Granted Jul 30, 2024·0 cites·10 claims
- 1586US11975001B2Immediate release pharmaceutical formulation of 4-[3-(4-cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2H-phthalazin-1-oneKUDOS PHARM LTD·Filed 2023·Granted May 7, 2024·0 cites·13 claims
- 1686US9169235B2Phthalazinone derivativesKUDOS PHARM LTD·Filed 2014·Granted Oct 27, 2015·5 cites·12 claims
- 1785US7049313B2ATM inhibitorsKUDOS PHARM LTD·Filed 2003·Granted May 23, 2006·19 cites·9 claims
- 1884US10449192B2Phthalazinone derivativesKUDOS PHARM LTD·Filed 2018·Granted Oct 22, 2019·2 cites·4 claims
- 1979US11160803B2Phthalazinone derivativesKUDOS PHARM LTD·Filed 2019·Granted Nov 2, 2021·0 cites·9 claims
- 2078US2022249474A1Immediate release pharmaceutical formulation of 4-[3-(4-cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2h-phthalazin-1-oneKUDOS PHARM LTD·Filed 2021·Application pending·0 cites
- 2177US7696203B2DNA-PK inhibitorsKUDOS PHARM LTD·Filed 2006·Granted Apr 13, 2010·4 cites·9 claims
- 2270US7429660B2ATM inhibitorsKUDOS PHARM LTD·Filed 2004·Granted Sep 30, 2008·4 cites·12 claims
- 2370US6753151B1Interactions of Ku polypeptides and applications thereofKUDOS PHARM LTD·Filed 2000·Granted Jun 22, 2004·9 cites·10 claims
- 2465US10034884B2Pyrido-, pyrazo- and pyrimido-pyrimidine derivatives as mTOR inhibitorsKUDOS PHARM LTD·Filed 2017·Granted Jul 31, 2018·0 cites·4 claims
- 2562US2017226124A1Phthalazinone derivativesKUDOS PHARM LTD·Filed 2017·Application pending·0 cites
- 2660US7902193B2Phthalazinone derivativesKUDOS PHARM LTD·Filed 2008·Granted Mar 8, 2011·0 cites·14 claims
- 2758US9717736B2Pyrido-, pyrazo- and pyrimido-pyrimidine derivatives as mTOR inhibitorsKUDOS PHARM LTD·Filed 2015·Granted Aug 1, 2017·0 cites·4 claims
- 2858US7732483B2DNA-PK inhibitorsKUDOS PHARM LTD·Filed 2008·Granted Jun 8, 2010·0 cites·11 claims
- 2958US2009043091A1Atm inhibitorsKUDOS PHARM LTD·Filed 2008·Application pending·0 cites
- 3058US2023015617A1Phthalazinone derivativesKUDOS PHARM LTD·Filed 2021·Application pending·0 cites
- 3151US7642254B2ATM inhibitorsKUDOS PHARM LTD·Filed 2006·Granted Jan 5, 2010·0 cites·3 claims
- 3247US2007049588A1Atm inhibitorKUDOS PHARM LTD·Filed 2006·Application pending·0 cites
- 3346US2009181951A1Parp inhibitorsKUDOS PHARM LTD·Filed 2007·Application pending·0 cites
- 3446US2009281086A12 -oxyheteroarylamide derivatives as parp inhibitorsKUDOS PHARM LTD·Filed 2007·Application pending·0 cites
- 3546US2009209520A12 -oxybenzamide derivatives as parp inhibitorsKUDOS PHARM LTD·Filed 2007·Application pending·0 cites
- 3645US2008194546A1Pyrido-, Pyrazo- and Pyrimido-Pyrimidine Derivatives as mTOR InhibitorsKUDOS PHARM LTD·Filed 2007·Application pending·0 cites
- 3743US2006199803A1CompoundsKUDOS PHARM LTD·Filed 2006·Application pending·0 cites
- 3843US2006135770A1PARP inhibitorsKUDOS PHARM LTD·Filed 2005·Application pending·0 cites
- 3941US7138236B1Interactions of ATM, ATR or DAN-PK with p53KUDOS PHARM LTD·Filed 1998·Granted Nov 21, 2006·6 cites·2 claims
- 4036US2007161808A1Process for the preparation of aq4nKUDOS PHARM LTD·Filed 2005·Application pending·0 cites
- 4134US6242175B1Methods and means relating to retrotransposon and retroviral integrationKUDOS PHARM LTD·Filed 1998·Granted Jun 5, 2001·8 cites·15 claims
- 4227US6753158B1Assays, agents, therapy and diagnosis relating to modulation of cellular DNA repair activityKUDOS PHARM LTD·Filed 1998·Granted Jun 22, 2004·4 cites·3 claims
Join the waitlist — get patent alerts
Get an alert when KUDOS PHARM LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →